Adiponectin levels remained significantly lower in those with COVID‐19 after adjustment for age, sex, BMI, pre‐existing diabetes mellitus, enteral nutrition, glucocorticoid therapy, total insulin, APACHE II score, and SOFA score (Figure 1). This evidence concerns the gene ADIPOQ and diabetes mellitus.